Interestingly, in a different study, TRF-treated neuroblastoma cells showed similar improvements in antioxidative and AD-related GSK3B and TAU protein markers (of tau hyperphosphorylation and neurofibrillary tangle formation) compared to controls [20]. Here, MAPT is linked to neuroblastoma.